CNS Pharmaceuticals CNSP
NASDAQ CNSP
$5.37 +0.13 (+2.59%)
As of: Oct 2, 2026 · 11:47 AM EDT

CNS Pharmaceuticals (CNSP) Return on Assets [ROA] (2019 - 2025)

Updated

CNS Pharmaceuticals' Return on Assets [ROA] came in at -156.17% for Q4 2025, up 29.03 percentage points from -185.20% a year earlier but down 55.96 percentage points from the prior quarter.

Analysis

CNS Pharmaceuticals (CNSP) Return on Assets [ROA] (2019 - 2025) Analysis & Trends

For FY2025, CNS Pharmaceuticals' Return on Assets [ROA] was -184.73%, up 102.11 percentage points from FY2024.

  • Return on Assets [ROA] carries a five-year change of -105.14 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Assets [ROA] was -286.84% in FY2024 (-30.92 pp), -255.92% in FY2023 (-115.85 pp), -140.06% in FY2022 (-22.27 pp) and -117.80% in FY2021 (-38.20 pp).
  • The five-year range for quarterly Return on Assets [ROA] is -1041.04% (Q1 2024) to -76.58% (Q1 2021).
  • Year-over-year, Return on Assets [ROA] has increased for six consecutive quarters, with an average year-over-year change of +159.28 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Assets [ROA] over five years came in Q1 2025 (a gain of 901.08 percentage points), and the weakest in Q1 2024 (a drop of 874.39 percentage points).
  • Business Quant data shows CNSP's Return on Assets [ROA] at -100.21% (Q3 2025), -110.35% (Q2 2025) and -139.96% (Q1 2025) in the three quarters before Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 CNS Pharmaceuticals 2.35 Mn -39.89 Mn - -156.17%
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -156.17%
Sep 30, 2025 -100.21%
Jun 30, 2025 -110.35%
Mar 31, 2025 -139.96%
Dec 31, 2024 -185.20%
Sep 30, 2024 -346.15%
Jun 30, 2024 -774.89%
Mar 31, 2024 -1,041.04%
Dec 31, 2023 -937.17%
Sep 30, 2023 -424.47%
Jun 30, 2023 -252.66%
Mar 31, 2023 -166.64%
Dec 31, 2022 -134.63%
Sep 30, 2022 -121.27%
Jun 30, 2022 -97.36%
Mar 31, 2022 -113.96%
Dec 31, 2021 -143.06%
Sep 30, 2021 -110.67%
Jun 30, 2021 -90.88%
Mar 31, 2021 -76.58%
API Access

CNS Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CNSP&period=max&api_key=YOUR_API_KEY